These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study]. Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U. Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961 [Abstract] [Full Text] [Related]
3. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS. Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693 [Abstract] [Full Text] [Related]
8. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H. Bone Marrow Transplant; 2000 Apr; 25(7):697-703. PubMed ID: 10745253 [Abstract] [Full Text] [Related]
9. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Grodman H, Wolfe L, Kretschmar C. Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417 [Abstract] [Full Text] [Related]
13. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, Rademaker A, Marymount M, Kalapurakal J, Haut PR, Duerst R, Kletzel M. J Clin Oncol; 2004 Jul 15; 22(14):2885-90. PubMed ID: 15254057 [Abstract] [Full Text] [Related]
14. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. MacDonald TJ, Arenson EB, Ater J, Sposto R, Bevan HE, Bruner J, Deutsch M, Kurczynski E, Luerssen T, McGuire-Cullen P, O'Brien R, Shah N, Steinbok P, Strain J, Thomson J, Holmes E, Vezina G, Yates A, Phillips P, Packer R. Cancer; 2005 Dec 15; 104(12):2862-71. PubMed ID: 16315242 [Abstract] [Full Text] [Related]
15. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma. Zia MI, Forsyth P, Chaudhry A, Russell J, Stewart DA. Bone Marrow Transplant; 2002 Nov 15; 30(9):565-9. PubMed ID: 12407430 [Abstract] [Full Text] [Related]
18. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study. Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP. Pediatr Blood Cancer; 2011 Sep 15; 57(3):506-13. PubMed ID: 21744474 [Abstract] [Full Text] [Related]
19. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. Bone Marrow Transplant; 2003 May 15; 31(9):755-61. PubMed ID: 12732881 [Abstract] [Full Text] [Related]